Your browser doesn't support javascript.
loading
SH2 domain-containing inositol 5-phosphatases support the survival of Burkitt lymphoma cells by promoting energy metabolism.
Mayr, Florian; Kruse, Vanessa; Fuhrmann, Dominik C; Wolf, Sebastian; Löber, Jens; Alsouri, Saed; Paglilla, Nadia; Lee, Kwang; Chapuy, Björn; Brüne, Bernhard; Zenz, Thorsten; Häupl, Björn; Oellerich, Thomas; Engelke, Michael.
Afiliação
  • Mayr F; Institute for Cellular and Molecular Immunology, University Medical Center Göttingen.
  • Kruse V; Institute for Cellular and Molecular Immunology, University Medical Center Göttingen.
  • Fuhrmann DC; Institute for Biochemistry I, Faculty of Medicine, Johann Wolfgang Goethe-University Frankfurt.
  • Wolf S; Department of Hematology/Oncology, Johann Wolfgang Goethe University, Frankfurt.
  • Löber J; Department of Hematology, Oncology and Cancer Immunology, Charité, Campus Benjamin Franklin.
  • Alsouri S; Institute for Cellular and Molecular Immunology, University Medical Center Göttingen.
  • Paglilla N; Institute for Cellular and Molecular Immunology, University Medical Center Göttingen.
  • Lee K; Translational Medical Oncology, German Cancer Research Center and National Center for Tumor Diseases, Heidelberg.
  • Chapuy B; Department of Hematology, Oncology and Cancer Immunology, Charité, Campus Benjamin Franklin.
  • Brüne B; Institute for Biochemistry I, Faculty of Medicine, Johann Wolfgang Goethe-University Frankfurt.
  • Zenz T; Department of Medical Oncology and Hematology, University Hospital Zurich.
  • Häupl B; Department of Hematology/Oncology, Johann Wolfgang Goethe University, Frankfurt, Germany; German Cancer Consortium (DKTK), Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; Frankfurt Cancer Institute, Johann Wolfgang Goethe University Frankfurt, Frankfurt.
  • Oellerich T; Department of Hematology/Oncology, Johann Wolfgang Goethe University, Frankfurt, Germany; German Cancer Consortium (DKTK), Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; Frankfurt Cancer Institute, Johann Wolfgang Goethe University Frankfurt, Frankfurt.
  • Engelke M; Institute for Cellular and Molecular Immunology, University Medical Center Göttingen. michael.engelke@med.uni-goettingen.de.
Haematologica ; 2023 Nov 02.
Article em En | MEDLINE | ID: mdl-37916396
ABSTRACT
Burkitt lymphoma cells (BL) exploit antigen-independent tonic signals transduced by the B cell antigen receptor (BCR) for their survival, but the molecular details of the rewired BLspecific BCR signal network remain unclear. A loss of function screen revealed the SH2 domain-containing 5`-inositol phosphatase 2 (SHIP2) as a potential modulator of BL fitness. We characterized the role of SHIP2 in BL survival in several BL cell models and show that perturbing SHIP2 function renders cells more susceptible to apoptosis, while attenuating proliferation in a BCR-dependent manner. Unexpectedly, SHIP2 deficiency did neither affect PI3K survival signals nor MAPK activity, but attenuated ATP production. We found that an efficient energy metabolism in BL cells requires phosphatidylinositol-3,4-bisphosphate (PI(3,4)P2), which is the enzymatic product of SHIP proteins. Consistently, interference with the function of SHIP1 and SHIP2 augments BL cell susceptibility to PI3K inhibition. Notably, we here provide a molecular basis of how tonic BCR signals are connected to energy supply, which is particularly important for such an aggressively growing neoplasia. These findings may help to improve therapies for the treatment of BL by limiting energy metabolism through the inhibition of SHIP proteins, which renders BL cells more susceptible to the targeting of survival signals.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article